A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation

Completed · Phase 3 · Has a placebo group

Conditions studied: Opioid-Induced Constipation (OIC)

In brief

The purpose of this study is to evaluate the effect and safety of NKTR-118 treatment of opioid-induced constipation in patients with non-cancer-related pain over a 6-month period.

Key facts

Study ID

NCT01395524

Run by

AstraZeneca

People needed

302

Starts

2011-07-01

Expected to finish

2012-09-01

Last updated by the study team

2017-02-23

Who can join

Age: 18 and older, up to 84. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must have completed the 12-week study D3820C00004 through Visit 8.
• Provision of written informed consent prior to any study-specific procedures.
• Men and women who were between the ages of >18 and <85 years at the time of the screening visit for study D3820C00004.
• Continuing to receive a stable maintenance opioid regimen consisting of a total daily dose of 30 mg to 1000 mg of oral morphine, or equianalgesic amount(s) of 1 or more other opioid therapies.
• Willingness to continue abstinence from all laxatives and other bowel regimens including prune juice and herbal products throughout this additional 12-week treatment period, and to use only bisacodyl as rescue medication if a bowel movement (BM) has not occurred within at least 72 hours of the last recorded BM.

You may not qualify if…

• Patients receiving opioid regimen for treatment of pain related to cancer.
• History of cancer within 5 years from the screening visit of study D3820C00004 with the exception of basal cell cancer and squamous cell skin cancer.
• Medical conditions and treatments associated with diarrhea, intermittent loose stools, or constipation.
• Other issues related to the gastrointestinal tract that could impose risk to the patient.
• Pregnancy or lactation.

Where it is running

• Research Site — Calera, Alabama, United States
• Research Site — Glendale, Arizona, United States
• Research Site — Mesa, Arizona, United States
• Research Site — Phoenix, Arizona, United States
• Research Site — Tucson, Arizona, United States
• Research Site — Hot Springs, Arkansas, United States
• Research Site — Malvern, Arkansas, United States
• Research Site — Anaheim, California, United States
• Research Site — Beverly Hills, California, United States
• Research Site — Burbank, California, United States
• Research Site — Garden Grove, California, United States
• Research Site — Laguana Hills, California, United States
• Research Site — Laguna Hills, California, United States
• Research Site — Long Beach, California, United States
• Research Site — Los Gatos, California, United States
• Research Site — Montebello, California, United States
• Research Site — National City, California, United States
• Research Site — Norwalk, California, United States
• Research Site — Paramount, California, United States
• Research Site — Sacramento, California, United States
• Research Site — San Diego, California, United States
• Research Site — Santa Ana, California, United States
• Research Site — Denver, Colorado, United States
• Research Site — Boynton Beach, Florida, United States
• Research Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.